SCHMERTZLER MICHAEL 4
4 · PTC THERAPEUTICS, INC. · Filed Jan 10, 2024
Insider Transaction Report
Form 4
SCHMERTZLER MICHAEL
Director
Transactions
- Sale
Common Stock
2024-01-08$27.81/sh−1,500$41,715→ 115,266 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023, to satisfy tax obligations in connection with the vesting of 4,664 restricted stock units from a January 5, 2023 grant of 8,000 restricted stock units.